- Home
- NVCR vs STRA Comparison
NVCR vs STRA Comparison
Compare NVCR & STRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCR
- STRA
- Stock Information
- Founded
- NVCR 2000
- STRA 2017
- Country
- NVCR Switzerland
- STRA United States
- Employees
- NVCR N/A
- STRA N/A
- Industry
- NVCR Medical/Dental Instruments
- STRA Other Consumer Services
- Sector
- NVCR Health Care
- STRA Real Estate
- Exchange
- NVCR Nasdaq
- STRA Nasdaq
- Market Cap
- NVCR 1.9B
- STRA 2.0B
- IPO Year
- NVCR 2015
- STRA 1996
- Fundamental
- Price
- NVCR $16.69
- STRA $86.20
- Analyst Decision
- NVCR Buy
- STRA Strong Buy
- Analyst Count
- NVCR 6
- STRA 3
- Target Price
- NVCR $32.83
- STRA $112.67
- AVG Volume (30 Days)
- NVCR 1.6M
- STRA 144.0K
- Earning Date
- NVCR 07-24-2025
- STRA 07-30-2025
- Dividend Yield
- NVCR N/A
- STRA 2.85%
- EPS Growth
- NVCR N/A
- STRA 11.28
- EPS
- NVCR N/A
- STRA 4.68
- Revenue
- NVCR $621,711,000.00
- STRA $1,233,270,000.00
- Revenue This Year
- NVCR $5.56
- STRA $6.07
- Revenue Next Year
- NVCR $9.19
- STRA $5.02
- P/E Ratio
- NVCR N/A
- STRA $17.99
- Revenue Growth
- NVCR 18.27
- STRA 5.72
- 52 Week Low
- NVCR $14.17
- STRA $74.28
- 52 Week High
- NVCR $34.13
- STRA $121.60
- Technical
- Relative Strength Index (RSI)
- NVCR 43.44
- STRA 49.00
- Support Level
- NVCR $17.20
- STRA $82.90
- Resistance Level
- NVCR $18.02
- STRA $85.02
- Average True Range (ATR)
- NVCR 1.04
- STRA 2.14
- MACD
- NVCR -0.09
- STRA -0.54
- Stochastic Oscillator
- NVCR 15.51
- STRA 33.24
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.
About STRA Strategic Education Inc.
Strategic Education Inc. is an education services company that provides access to high-quality education through campus-based and online post-secondary education offerings, as well as through programs to develop job-ready skills for high-demand markets. The company operates through wholly-owned subsidiaries Strayer University and Capella University, both accredited post-secondary institutions of higher education located in the United States, as well as Torrens University, an accredited post-secondary institution of higher education located in Australia. It provide employees with access to affordable and industry relevant training, certificate, and degree programs. The reportable segments of the company are U.S. Higher Education, Australia/New Zealand and Education Technology Services.